Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$8.60
-0.41-4.55%
Last update: Oct 9, 3:59 PM
Palatin Technologies Inc (PTN) Stock Price, Quote, News & History
PTNNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system. Its product candidates are targeted, receptor-specific therapeutics...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Palatin Technologies (NASDAQ:PTN) through any online brokerage.
Other companies in Palatin Technologies’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Palatin Technologies has a consensus price target of $33.50.
The stock price for Palatin Technologies (NASDAQ: PTN) is $8.48 last updated October 9, 2026 at 3:59 PM EDT.
There are no upcoming dividends for Palatin Technologies.
Palatin Technologies does not have any upcoming earnings scheduled.
There is no upcoming split for Palatin Technologies.
Palatin Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
